Biohope is a partner of MiSOT, an specialist Consortium focused on the use of mesenchymal stem cells (MSC) and related multipotent adult progenitor cells (MAPC) in the field of solid organ transplantation. MiSOT aims to bring together academic and commercial research with the goal of bringing mesenchymal stem cell therapies to the transplantation clinic. This platform will also be used to update on the latest clinical trial protocols and scientific news.